489 results on '"Réus, Gislaine Z."'
Search Results
2. Environmental Enrichment Rescues Oxidative Stress and Behavioral Impairments Induced by Maternal Care Deprivation: Sex- and Developmental-Dependent Differences
3. Neuroprotection induced by neurotrophic factors
4. List of contributors
5. Pre- and Post-Synaptic protein in the major depressive Disorder: From neurobiology to therapeutic targets
6. Peripheral biomarkers as a predictor of poor prognosis in severe cases of COVID-19
7. Major depressive disorder as a neuro-immune disorder: Origin, mechanisms, and therapeutic opportunities
8. Stress levels, psychological symptoms, and C-reactive protein levels in COVID-19: A cross-sectional study
9. Definitions and Concepts of Stress
10. Role of Glutamatergic Neurotransmission in the Pathophysiology of Stress-Related Disorders and Chronic Stress Response
11. Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease
12. Sex differences on the response to antidepressants and psychobiotics following early life stress in rats
13. Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats
14. Environmental enrichment improves lifelong persistent behavioral and epigenetic changes induced by early-life stress
15. Pathophysiological Mechanisms of Huntington’s Disease
16. Physical Exercise and Neuroinflammation in Major Depressive Disorder
17. New Perspective on mTOR Pathways: A New Target of Depression
18. The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research
19. Maternal deprivation increases microglial activation and neuroinflammatory markers in the prefrontal cortex and hippocampus of infant rats
20. Imipramine treatment reverses depressive- and anxiety-like behaviors, normalize adrenocorticotropic hormone, and reduces interleukin-1β in the brain of rats subjected to experimental periapical lesion
21. ω-3 and folic acid act against depressive-like behavior and oxidative damage in the brain of rats subjected to early- or late-life stress
22. The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
23. Early Maternal Deprivation Induces Microglial Activation, Alters Glial Fibrillary Acidic Protein Immunoreactivity and Indoleamine 2,3-Dioxygenase during the Development of Offspring Rats
24. Early life experience contributes to the developmental programming of depressive-like behaviour, neuroinflammation and oxidative stress
25. The impact of chronic mild stress on long-term depressive behavior in rats which have survived sepsis
26. Mechanism of synergistic action on behavior, oxidative stress and inflammation following co-treatment with ketamine and different antidepressant classes
27. Pathophysiological mechanisms involved in the relationship between diabetes and major depressive disorder
28. Effects of ketamine administration on mTOR and reticulum stress signaling pathways in the brain after the infusion of rapamycin into prefrontal cortex
29. Chapter 28 - Neuroprotection induced by neurotrophic factors
30. Neuro-Immune Interactions in Depression: Mechanisms and Translational Implications
31. Intracellular Signaling Pathways Implicated in the Pathophysiology of Depression
32. Contributors
33. Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders
34. Natural Phytochemicals for the Treatment of Major Depressive Disorder: A Mini-Review of Pre- and Clinical Studies
35. Neurochemical correlation between major depressive disorder and neurodegenerative diseases
36. Effects of ketamine administration on the phosphorylation levels of CREB and TrKB and on oxidative damage after infusion of MEK inhibitor
37. Pathophysiological Mechanisms of Huntington’s Disease
38. ABO Blood Type and Metabolic Markers in COVID-19 Susceptibility and Severity: A Cross-Sectional Study.
39. Methylphenidate increases glucose uptake in the brain of young and adult rats
40. Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies
41. The contribution of gut-brain axis to development of neurological symptoms in COVID-19 recovered patients: A hypothesis and review of literature
42. Beneficial effects and neurobiological aspects of environmental enrichment associated to major depressive disorder and autism spectrum disorder
43. Acute and long-term effects of intracerebroventricular administration of α-ketoisocaproic acid on oxidative stress parameters and cognitive and noncognitive behaviors
44. Ketamine Exhibits Different Neuroanatomical Profile After Mammalian Target of Rapamycin Inhibition in the Prefrontal Cortex: the Role of Inflammation and Oxidative Stress
45. Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain
46. Bimodal effect of ketamine on neurotrophic factors and inflammatory parameters in cecal ligation and puncture-induced sepsis model
47. Animal models of social anxiety disorder and their validity criteria
48. MAPK signaling correlates with the antidepressant effects of ketamine
49. The role of mTOR in depression and antidepressant responses
50. New Perspective on mTOR Pathways: A New Target of Depression
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.